Shares of Boston Scientific Corporation (NYSE:BSX) ended Thursday session in red amid volatile trading. The shares closed down -0.60 points or -2.72% at $21.49 with 16.06 million shares getting traded. Post opening the session at $22.17, the shares hit an intraday low of $21.43 and an intraday high of $22.19 and the price vacillated in this range throughout the day. The company has a market cap of $28.79 billion and the numbers of outstanding shares have been calculated to be 1.36 billion shares.
Boston Scientific Corporation (BSX) announced that Professor Ian Meredith AM will join the company as executive vice president and global chief medical officer in January 2017. In his new position, Professor Meredith will lead clinical and medical affairs across Boston Scientific and will provide global leadership of the company’s clinical trial strategy.
Professor Meredith will succeed Executive Vice President and Global Chief Medical Officer Keith Dawkins, M.D., who has announced his intention to retire from the company in January 2017.
“Ian is one of the world’s leading cardiac device clinical investigators and he has been an advisor to Boston Scientific for many years,” said Mike Mahoney, chairman and chief executive officer, Boston Scientific. “His strong relationships within the global research and clinical community and his track record applying novel technologies to advance science and care for patients make him ideally suited to drive innovation and succeed Keith in this role. We are delighted that he will be joining our team.”
Shares of Johnson & Johnson (NYSE:JNJ) ended Thursday session in green amid volatile trading. The shares closed up +1.14 points or 1.00% at $115.70 with 7.55 million shares getting traded. Post opening the session at $114.98, the shares hit an intraday low of $114.79 and an intraday high of $116.55 and the price vacillated in this range throughout the day. The company has a market cap of $318.21 billion and the numbers of outstanding shares have been calculated to be 2.74 billion shares.
Johnson & Johnson (JNJ) announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2016 of $0.80 per share on the company’s common stock. The dividend is payable on December 6, 2016 to shareholders of record at the close of business on November 22, 2016. The ex-dividend date is November 18, 2016.